Stuart D. Shumway, Ph.D. - Publications

Affiliations: 
2001 University of Wisconsin, Madison, Madison, WI 
Area:
Molecular Biology, Cell Biology, Immunology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Celano SL, Yco LP, Kortus MG, Solitro AR, Gunaydin H, Scott M, Spooner E, O'Hagan RC, Fuller P, Martin KR, Shumway SD, MacKeigan JP. Identification of Kinases Responsible for p53-Dependent Autophagy. Iscience. 15: 109-118. PMID 31048145 DOI: 10.1016/J.Isci.2019.04.023  0.321
2013 Guertin AD, Li J, Liu Y, Hurd MS, Schuller AG, Long B, Hirsch HA, Feldman I, Benita Y, Toniatti C, Zawel L, Fawell SE, Gilliland DG, Shumway SD. Preclinical evaluation of the WEE1 inhibitor MK-1775 as single-agent anticancer therapy. Molecular Cancer Therapeutics. 12: 1442-52. PMID 23699655 DOI: 10.1158/1535-7163.MCT-13-0025  0.31
2012 Aarts M, Sharpe R, Garcia-Murillas I, Gevensleben H, Hurd MS, Shumway SD, Toniatti C, Ashworth A, Turner NC. Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of WEE1. Cancer Discovery. 2: 524-39. PMID 22628408 DOI: 10.1158/2159-8290.CD-11-0320  0.312
2005 O'Connor S, Shumway S, Miyamoto S. Inhibition of IkappaBalpha nuclear export as an approach to abrogate nuclear factor-kappaB-dependent cancer cell survival. Molecular Cancer Research : McR. 3: 42-9. PMID 15671248  0.693
2004 O'Connor S, Shumway SD, Amanna IJ, Hayes CE, Miyamoto S. Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells. Molecular and Cellular Biology. 24: 4895-908. PMID 15143182 DOI: 10.1128/Mcb.24.11.4895-4908.2004  0.67
2004 Shumway SD, Miyamoto S. A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells. The Biochemical Journal. 380: 173-80. PMID 14763901 DOI: 10.1042/Bj20031796  0.741
2002 Shumway SD, Berchtold CM, Gould MN, Miyamoto S. Evidence for unique calmodulin-dependent nuclear factor-kappaB regulation in WEHI-231 B cells. Molecular Pharmacology. 61: 177-85. PMID 11752219 DOI: 10.1124/Mol.61.1.177  0.736
2000 Huang TT, Wuerzberger-Davis SM, Seufzer BJ, Shumway SD, Kurama T, Boothman DA, Miyamoto S. NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events. The Journal of Biological Chemistry. 275: 9501-9. PMID 10734098 DOI: 10.1074/Jbc.275.13.9501  0.639
1999 Shumway SD, Maki M, Miyamoto S. The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain. The Journal of Biological Chemistry. 274: 30874-81. PMID 10521480 DOI: 10.1074/Jbc.274.43.30874  0.574
1998 Miyamoto S, Seufzer BJ, Shumway SD. Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells. Molecular and Cellular Biology. 18: 19-29. PMID 9418849 DOI: 10.1128/Mcb.18.1.19  0.649
Show low-probability matches.